News
Brief news reports on Tuberculosis
By
International Union Against Tuberculosis and Lung Disease
Published: Sept. 11, 2020, 1:13 p.m.·
Tags:
Global TB response,
Public health
The International Journal of Tuberculosis and Lung Disease (IJTLD) is the official publication of the International Union Against Tuberculosis and Lung Disease (The Union).
Read More →
By
Unitaid NGO Delegation
Published: Sept. 10, 2020, 2:29 p.m.·
Tags:
Advocacy
The NGO Delegation to the Unitaid Board is currently recruiting for two roles: Alternate Board Member and Key Advisor.
Read More →
By
Nkechi Onyedika-Ugoeze
Published: Sept. 10, 2020, 1:30 a.m.·
Tags:
TB programs
The National Coordinator, National Tuberculosis and Leprosy Control Programme (NTBLCP), Dr. Adebola Lawanson, has urged the Federal Government to put in place policies that will integrate tuberculosis into the COVID-19 response.
Read More →
By
Namita Kohli
Published: Sept. 9, 2020, 3:05 p.m.·
Tags:
TB programs
COVID-19 has proved to be a major obstacle in India's tuberculosis programme. Between the months of January and June this year, about 5.7 lakh cases (62 per cent of the notifications) of tuberculosis could not be notified. Only about half of TB patients in the country received money from the government for nutritional support during their treatment, according to the Union health ministry.
Read More →
By
Treatment Action Group
Published: Sept. 8, 2020, 2:11 p.m.·
Tags:
Global health,
Global TB response,
Research and development,
Advocacy
Sustained and expanded financing is needed to safeguard TB research against COVID-19–related disruptions and improve global epidemic preparedness.
Read More →
By
TuBerculosis Vaccine Initiative (TBVI)
Published: Sept. 7, 2020, 1:21 p.m.·
Tags:
Vaccines,
Research and development
The European Investment Bank (EIB) agreed a €30 million loan with Vakzine Projekt Management GmbH (VPM), the German subsidiary of Serum Institute of India Pvt. Ltd. The loan will help VPM to perform the priMe trial. The priMe project contains a multicentre phase III double-blind, randomised, controlled study to evaluate the efficacy and safety of VPM1002 in comparison to the baccille Calmette–Guérin (BCG) vaccine. Vaccine research and development for the project will be carried out by VPM and the clinical trials will be scaled up in several high-burden sub-Saharan African countries.
Read More →
By
Eamon N. Dreisbach
Published: Sept. 3, 2020, 3:18 p.m.·
Tags:
TB epidemiology
HIV and tuberculosis were independently associated with an increased risk for COVID-19 mortality in a South African study that included more than 22,000 patients with the new disease, researchers reported in Clinical Infectious Diseases.
Read More →
By
civil society
Published: Sept. 2, 2020, 4:44 p.m.·
Tags:
Global TB response,
Advocacy
The results of the global civil-society led survey about the impact of COVID-19 on the TB epidemic will be virtually launched on 15 September 2020.
Read More →
By
Kenny Walter
Published: Sept. 2, 2020, 2:59 p.m.·
Tags:
TB care
The incidence of active tuberculosis (TB) in patients following kidney transplants is significantly higher than the general population. While researchers in the past have described this as presenting in the first year following solid organ transplantation and is predominantly caused by disease reactivation.
Read More →
By
TBpeople
Published: Sept. 1, 2020, 4 p.m.·
Tags:
Advocacy
The global secretariat of TBpeople is hiring a part-time Administration and Finance Assistant.
Read More →
Page 176 of 895 · Total posts: 10
←First
175
176
177
Last→